system
inhibit
suffici
quantiti
neuropathi
target
esteras
nte
certain
organophosphoru
op
compound
produc
op
compoundinduc
delay
neurotox
opidn
distal
degener
axon
central
nervou
system
cn
peripher
nervou
system
pn
therebi
provid
power
model
studi
spectrum
neurodegen
diseas
axonopathi
import
medic
entiti
right
watson
dyck
addit
ill
consid
primari
neuronopathi
thought
begin
axon
degener
disord
includ
alzheim
diseas
liang
et
al
stokin
et
al
yuan
et
al
parkinson
diseas
burk
omalley
pelzer
et
al
tagliaferro
et
al
motor
neuron
diseas
amyotroph
later
sclerosi
al
fischer
et
al
moloney
et
al
venkova
et
al
moreov
condit
knockout
nte
mous
cn
produc
vacuol
degen
chang
larg
neuron
hippocampu
thalamu
cerebellum
akassogl
et
al
along
degener
swell
axon
ascend
descend
spinal
cord
tract
read
et
al
human
nte
mutat
caus
varieti
neurodegen
condit
result
rang
deficit
includ
spastic
paraplegia
blind
hufnagel
et
al
kmoch
et
al
synofzik
et
al
mutat
drosophila
nte
orthologu
swisschees
sw
produc
neurodegener
character
vacuol
partial
rescu
express
wildtyp
human
nte
suggest
potenti
therapeut
approach
certain
human
neurolog
disord
sujkowski
et
al
sunderhau
et
al
chapter
defin
nte
opidn
present
overview
op
compound
provid
rational
nte
research
trace
histori
discoveri
nte
relationship
opidn
briefli
describ
subsequ
studi
nte
includ
practic
applic
assay
aspect
domain
structur
subcellular
local
tissu
express
abnorm
associ
nte
mutat
knockdown
convent
condit
knockout
hypothet
model
help
guid
futur
research
elucid
role
nte
opidn
neuropathi
target
esteras
nte
formerli
call
neurotox
esteras
johnson
also
known
patatinlik
phospholipas
domaincontain
protein
sixth
member
nineprotein
famili
patatin
domain
lipid
hydrolas
protein
express
human
kienesberg
et
al
nte
encod
gene
locat
human
chromosom
contain
exon
give
rise
least
splice
variant
canon
protein
sequenc
uniprot
nation
center
biotechnolog
inform
ncbi
isoforma
amino
acid
residu
gene
highli
conserv
evolutionarili
orthologu
divers
speci
includ
drosophila
zebrafish
chicken
mous
rat
chimpanze
ncbi
uniprot
nte
protein
express
ubiquit
tissu
anchor
endoplasm
reticulum
er
cell
highest
level
lung
testi
spleen
brain
kidney
ncbi
nte
multipl
role
develop
includ
neurit
outgrowth
vasculogenesi
moser
et
al
adult
protein
appear
involv
axon
mainten
neuron
read
et
al
regul
osmolar
kidney
gallazzini
et
al
biochem
nte
serin
hydrolas
phospholipas
b
activ
uniprot
nte
possess
phospholipas
activ
sequenti
deacyl
acyl
bond
phosphatidylcholin
ptdcho
cleavag
bond
ratelimit
follow
rapid
hydrolysi
bond
yield
glycerophosphocholin
gropcho
free
fatti
acid
ffa
rcooh
glynn
van
tienhoven
et
al
fig
moreov
enzymat
activ
nte
enhanc
presenc
phospholipidsin
particular
phosphatidylcholin
davi
richardson
pope
padilla
lysophospholipid
hydrolysi
catalyt
domain
nte
artifici
bilay
membran
alter
membran
fluiditi
greiner
et
al
given
phospholipas
capabl
anchorag
er
like
nte
play
role
membran
lipid
homeostasi
zaccheo
et
al
fig
catalyt
activ
nte
phospholipas
b
substrat
phosphatidylcholin
ptdcho
sequenti
hydrolyz
nte
shown
blue
first
posit
ratelimit
yield
lysophosphatidylcholin
lysoptdcho
free
fatti
acid
ffa
follow
rapid
cleavag
posit
yield
glycerophosphatidylcholin
gropcho
ffa
glynn
van
tienhoven
et
al
r
r
repres
hydrocarbon
chain
ffa
compon
phospholipid
nte
first
identifi
systemat
experiment
search
site
initi
delay
centralperipher
distal
axonopathi
cpda
brought
suffici
high
singl
repeat
exposur
certain
op
compoundsa
syndrom
call
opidn
aboudonia
carrington
richardson
et
al
wijeyesaker
richardson
cpda
term
use
describ
pattern
lesion
found
opidn
number
neurodegen
condit
wherebi
distal
degener
axon
occur
cn
pn
moretto
et
al
spencer
schaumburg
op
compound
produc
opidn
term
neuropath
variat
name
ascrib
chemic
induc
axon
degener
includ
organophosphoru
organophosphoru
ester
organophosph
instead
op
compound
andor
neuropathi
instead
neurotox
aboudonia
cherniak
emerick
et
al
masoud
sandhir
addit
author
favor
polyneuropathi
neuropathi
neurotox
case
acronym
becom
opidp
jokanovi
c
et
al
jokanovi
c
et
al
lotti
moretto
monroynoyola
et
al
chapter
use
opidn
rather
opidp
understand
term
indic
organophosphoru
compoundinduc
delay
neurotox
two
reason
first
chemic
standpoint
organophosphoru
correct
name
gener
class
chemic
contrast
organophosph
organophosphoru
ester
refer
specif
subclass
op
compound
eto
iupac
moreov
repres
number
op
subclass
produc
opidn
richardson
second
neurolog
perspect
neuropathi
polyneuropathi
rather
imprecis
term
usual
refer
patholog
occur
one
peripher
nerv
alber
hutton
et
al
karam
dyck
howev
opidn
affect
axon
ascend
descend
spinal
cord
tract
well
sensori
motor
axon
peripher
nerv
aboudonia
emerick
et
al
richardson
et
al
therefor
regard
delay
neurotox
within
context
exposur
neuropath
op
compound
better
descriptor
chemic
produc
condit
delay
neuropathi
delay
polyneuropathi
delay
aspect
opidn
refer
clinic
quiescent
period
exposur
neuropath
op
compound
appear
clinic
sign
symptom
hiatu
typic
day
emerick
et
al
period
week
report
lotti
moretto
motor
sensori
pathway
affect
opidn
along
distribut
progress
clinic
sign
symptom
shown
schemat
fig
motor
effect
includ
weak
ataxia
progress
bilater
paralysi
sensori
manifest
compris
bilater
paresthesia
numb
tingl
addit
cramp
lancin
muscl
pain
may
present
histopatholog
find
reveal
primari
distal
descend
axon
upper
motor
neuron
motor
cortex
brain
pass
along
corticospin
tract
synaps
lower
motor
neuron
anterior
horn
spinal
cord
lower
motor
neuron
send
axon
anterior
spinal
root
peripher
nerv
synaps
onto
muscl
b
sensori
pathway
sensori
neuron
dorsal
root
ganglion
send
ascend
branch
bifurc
axon
dorsal
posterior
column
spinal
cord
synaps
receiv
neuron
gracil
nucleu
brainstem
descend
branch
sensori
neuron
pass
dorsal
spinal
root
peripher
nerv
termin
sensori
organ
pacinian
corpuscl
sens
chang
pressur
pain
receptor
c
clinic
effect
dash
line
depict
stock
glove
distribut
sensori
effect
eg
paresthesia
motor
deficit
eg
paralysi
arrow
indic
spatialtempor
die
back
progress
distal
proxim
region
neuron
intact
myelin
axon
gray
distal
region
degener
axon
dot
green
line
green
yshape
sensori
organ
green
teardrop
muscl
dash
red
rectangl
aboudonia
bouldin
cavanagh
b
davi
richardson
lotti
moretto
axonopathi
accumul
tubulovesicular
element
accompani
secondari
demyelin
degener
preferenti
occur
long
largediamet
axon
sensori
motor
modal
mild
case
mainli
affect
lower
limb
sever
case
also
affect
trunk
upper
limb
clinic
cours
human
consist
initi
stock
glove
distribut
sensori
disturb
attenu
reflex
flaccid
paralysi
gradual
peripher
nerv
regener
occur
owe
persist
lesion
spinal
cord
tract
hyperreflexia
spastic
paralysi
superven
electrophysiolog
find
time
consist
clinic
interpret
cpda
follow
degre
peripher
nerv
regener
accompani
linger
central
nervou
system
involv
aboudonia
bouldin
cavanagh
b
davi
richardson
lotti
moretto
anim
studi
observ
human
case
reveal
follow
characterist
opidn
relationship
nte
carrington
aboudonia
glynn
johnson
johnson
lotti
moretto
moretto
et
al
richardson
et
al
richardson
et
al
richardson
makhaeva
within
speci
adult
vulner
opidn
juvenil
resist
within
speci
adult
recov
incomplet
opidn
juvenil
tend
recov
complet
within
speci
opidn
preferenti
affect
long
largediamet
axon
spinal
cord
peripher
nerv
within
speci
clinic
cours
begin
paresthesia
progress
weak
ataxia
hyporeflexia
flaccid
paralysi
mild
case
mainli
affect
lower
limb
sever
case
affect
lower
limb
upper
limb
trunk
left
recurr
laryng
nerv
longer
right
recurr
laryng
nerv
time
peripher
nerv
regener
spinal
lesion
persist
result
hyperreflexia
spastic
among
speci
larg
anim
eg
human
cattl
water
buffalo
sheep
pig
cat
chicken
tend
suscept
opidn
small
anim
eg
rat
mice
gerbil
guinea
pig
among
speci
larg
anim
tend
higher
nte
specif
activ
small
anim
among
speci
resist
opidn
tend
higher
nte
turnov
rate
suscept
opidn
threshold
inhibit
nervou
system
nte
necessari
suffici
opidn
ensu
inhibit
nte
must
also
undergo
age
loss
secondari
leav
group
op
moieti
yield
neg
charg
organophosphyl
group
coval
attach
activesit
serin
order
opidn
occur
nte
inhibit
brain
use
conveni
surrog
nte
inhibit
spinal
cord
peripher
nerv
anim
model
choic
opidn
studi
adult
hen
hen
clinic
sign
opidn
delay
day
time
achiev
inhibit
brain
nte
follow
singl
repeat
dose
neuropath
op
compound
tabl
summar
chemic
genom
manipul
nte
outcom
variou
speci
enigmat
controversi
aspect
nte
presumpt
role
opidn
appar
requir
age
inhibit
enzym
initi
event
axonopathi
theori
propos
inhibit
catalyt
activ
nte
enough
precipit
opidn
suitabl
chemic
modif
protein
also
requir
criterion
opidn
result
combin
loss
physiolog
function
gain
pathologicaltox
function
nte
rather
aris
loss
physiolog
function
alon
decad
research
focus
opidn
led
toxicologist
interim
conclus
glynn
richardson
et
al
hand
shall
see
recent
studi
direct
toward
understand
physiolog
pathogen
function
challeng
gain
toxic
function
hypothesi
favor
instead
seemingli
simpler
idea
opidn
due
prolong
inactiv
catalyt
activ
protein
loss
physiolog
function
glynn
read
et
al
seek
explan
might
reconcil
toxicolog
genet
find
keep
two
import
fact
mind
drug
toxic
act
exclus
singl
target
talevi
genet
chemic
manipul
given
target
elicit
compensatori
mechan
schenon
et
al
nte
discov
use
chemic
approach
could
done
without
prior
knowledg
chemistri
op
compound
aspect
biochemistri
toxicolog
therefor
brief
overview
materi
order
tend
think
op
compound
synthet
product
chemic
agrochem
pharmaceut
industri
mani
import
natur
constitu
life
op
compound
includ
dna
rna
phospholipid
cellular
membran
number
import
enzym
cofactor
metabol
intermedi
berg
et
al
even
natur
occur
op
compound
found
certain
bacteria
marin
spong
exhibit
high
potenc
acetylcholinesteras
ach
inhibitor
consequ
insecticid
activ
neumann
peter
petroianu
moreov
broadest
chemic
sens
op
compound
either
natur
occur
synthet
organ
molecul
contain
trival
pentaval
phosphoru
howev
chapter
focus
song
et
al
synthet
substanc
contain
pentaval
phosphoru
constitut
vast
major
exogen
op
compound
peopl
like
expos
addit
term
organophosphyl
use
indic
gener
op
group
attach
anoth
entiti
activ
site
esteras
recognit
fact
op
compound
could
number
subclass
eg
organophosph
organophosphon
organophosphin
organophosphoramid
likewis
organophosphyl
use
indic
gener
process
ad
op
group
protein
exampl
pentacoval
op
compound
shown
fig
note
phosphoru
atom
tetrahedr
consequ
chiral
give
rise
optic
isom
exampl
nerv
agent
soman
gd
methylphosphonofluorid
chiral
phosphoru
chiral
carbon
four
possibl
stereoisom
p
c
isom
soman
highest
inhibitori
potenc
ach
ordentlich
et
al
sanson
et
al
diisopropylphosphorofluorid
dfp
analogu
n
n
fluorid
mipafox
mip
age
inhibitor
nte
produc
opidn
diethyl
phosphat
fig
exampl
pentacoval
op
compound
pentacoval
phosphoru
atom
tetrahedr
consequ
chiral
yield
optic
isom
soman
chiral
phosphoru
chiral
carbon
yield
four
stereoisom
potent
antiach
isom
p
c
shown
malathion
chiral
carbon
r
isom
shown
commerci
insecticid
suppli
racem
mixtur
dfp
mip
analogu
age
inhibitor
nte
neuropath
paraoxon
pox
activ
metabolit
insecticid
parathion
effect
inhibitor
nte
neuropath
mipafox
mip
employ
nte
assay
select
neuropath
inhibitor
nte
wherea
pox
use
nonneuropath
inhibitor
fig
jianmongkol
et
al
johnson
kayyali
et
al
richardson
et
al
paraoxon
activ
metabolit
insecticid
diethyl
phosphorothio
parathion
pox
potent
antiach
compound
effect
inhibitor
nte
neuropath
lotti
johnson
diethyl
dimethoxyphosphorothioyl
sulfanyl
butanedio
malathion
wide
use
insecticid
requir
metabol
activ
parent
p
thion
form
activ
p
oxon
form
order
effect
inhibitor
ach
malathion
chiral
carbon
r
isom
shown
commerci
insecticid
suppli
racem
mixtur
neither
malathion
activ
metabolit
diethyl
dimethoxyphosphorylsulfanyl
butanedio
malaoxon
nte
inhibitor
neither
compound
neuropath
jianmongkol
et
al
lotti
moretto
op
compound
employ
myriad
form
flame
retard
fuel
addit
hydraul
fluid
lubric
pesticid
pharmaceut
plastic
davi
richardson
richardson
et
al
howev
perhap
best
known
us
use
insecticid
domest
agricultur
applic
cdc
op
insecticid
also
recogn
throughout
world
part
play
control
vectorborn
diseas
african
trypanosomiasi
chaga
diseas
dengu
leishmaniasi
lymphat
filariasi
malaria
recent
op
insecticid
press
increas
servic
compon
integr
vector
manag
amid
grow
concern
spread
mosquitoborn
virus
eastern
equin
enceph
west
nile
zika
cdc
usepa
consequ
widespread
use
op
compound
degre
exposur
inevit
throughout
popul
thu
prompt
need
understand
potenti
advers
health
outcom
proper
risk
assess
done
weigh
societ
benefit
use
product
episod
increas
exposur
wellintend
measur
vector
control
gener
controversi
alarm
reuter
heighten
need
trustworthi
data
health
effect
effect
commun
popul
potenti
risk
public
apprehens
surround
exposur
op
compound
understand
view
notorieti
highli
toxic
op
nerv
agent
rs
methylphosphonofluorid
gd
sarin
use
chemic
weapon
number
conflict
jamal
page
reportedli
includ
syrian
civil
war
brook
et
al
john
et
al
moreov
compound
use
civilian
popul
agent
chemic
terror
nozaki
et
al
okamura
et
al
suzuki
et
al
worek
et
al
continu
pose
threat
richardson
et
al
howev
reassur
note
nonoccup
exposur
lowlevel
environment
level
op
insecticid
thu
far
conclus
link
advers
neurolog
outcom
human
reiss
et
al
fig
show
interact
gener
op
inhibitor
serin
esteras
target
enzym
except
format
age
enzym
step
process
analog
hydrolysi
carboxyl
acid
ester
substrat
initi
interact
revers
wherebi
inhibitor
form
michaelistyp
complex
enzym
shown
blue
eoh
emphas
fig
interact
op
inhibitor
serin
esteras
esteras
blue
depict
eoh
emphas
activ
site
serin
hydroxyl
group
engag
nucleophil
attack
electroposit
phosphoru
atom
displac
leav
group
x
becom
organophosphyl
kinet
rate
constant
k
k
format
dissoci
respect
revers
opeoh
complex
k
phosphyl
k
spontan
reactiv
k
age
k
overal
bimolecular
rate
constant
inhibit
tetrahedr
op
inhibitor
progress
trigon
bipyramid
transit
state
collaps
tetrahedr
speci
coval
attach
activ
site
serin
residu
yield
inhibit
enzym
undergo
spontan
reactiv
age
age
enzym
intract
reactiv
even
power
nucleophil
oxim
richardson
richardson
et
al
r
r
substitut
unsubstitut
alkyl
aryl
group
differ
x
primari
leav
group
fluorin
serin
hydroxyl
nucleophil
attack
electroposit
phosphoru
atom
op
compound
rate
constant
k
k
indic
forward
revers
reaction
format
dissoci
respect
revers
complex
richardson
richardson
et
al
way
coval
inhibit
enzym
op
compound
morph
tetrahedr
geometri
trigon
bipyramid
transit
state
coval
acyl
phosphyl
occur
leav
group
x
rapidli
displac
transit
state
collaps
back
tetrahedr
geometri
step
character
rate
constant
phosphyl
k
yield
coval
inhibit
enzym
op
inhibitor
chiral
absenc
pseudorot
inhibit
would
expect
result
invers
chiral
phosphoru
eto
although
r
design
could
chang
depend
assign
group
prioriti
accord
cahningoldprelog
cip
rule
carbonel
et
al
epstein
et
al
dissoci
constant
revers
eohop
complex
approxim
eq
simplif
justifi
op
inhibitor
esteras
k
k
often
order
magnitud
smaller
k
k
usual
much
smaller
k
k
michaelistyp
equilibrium
constant
molar
unit
repres
concentr
requir
achiev
maximum
rate
product
acyl
phosphyl
enzym
see
fig
k
also
regard
measur
affin
op
inhibitor
bind
activ
site
enzym
thu
low
valu
k
correspond
high
affin
high
valu
k
correspond
low
affin
aldridg
reiner
main
richardson
et
al
overal
progress
reaction
enzym
eoh
inhibitor
ax
phosphyl
inhibit
enzym
eoa
expuls
primari
leav
group
x
character
bimolecular
rate
constant
inhibit
k
import
measur
inhibitori
potenc
determin
measur
activ
remain
function
time
preincub
enzym
variou
concentr
inhibitor
ax
eoh
ester
substrat
ad
preincub
interv
incub
period
determin
residu
activ
richardson
richardson
et
al
ax
k
k
given
eq
import
realiz
k
composit
acyl
phosphyl
rate
constant
unit
min
dissoci
equilibrium
constant
k
unit
therefor
k
unit
secondord
bimolecular
rate
constant
min
straightforward
determin
k
pseudofirstord
kinet
obtain
condit
commonli
occur
concentr
michaelistyp
revers
eohax
complex
low
k
high
k
k
ax
eoh
richardson
richardson
et
al
event
eq
appli
v
veloc
ie
rate
enzymat
hydrolysi
ester
substrat
time
v
rate
time
zero
substitut
vv
let
k
k
ax
ax
k
rearrang
yield
eq
ln
activ
k
ln
accordingli
plot
ln
activ
versu
straight
line
slope
yintercept
ln
shown
fig
primari
kinet
plot
moreov
experiment
determin
depend
ln
activ
preincub
time
inhibitor
concentr
ax
given
eq
set
eq
equal
give
eq
plot
vs
ax
straight
line
slope
k
shown
fig
secondari
kinet
plot
k
valu
measur
overal
inhibitori
potenc
given
compound
directact
op
inhibitor
particular
serin
esteras
ach
nte
import
realiz
k
composit
quantiti
includ
k
indic
affin
inhibitor
enzym
k
rate
organophosphyl
enzym
inhibitor
eq
unit
k
ax
k
obtain
chlorpyrifo
methyl
oxon
cpmo
hen
brain
ach
microsom
fraction
ph
phosphat
buffer
min
kropp
richardson
note
extrapol
primari
plot
exhibit
small
amount
zerotim
inhibit
indic
low
concentr
revers
michaelistyp
complex
substitut
percent
activ
interest
eq
give
inhibitor
concentr
given
time
preincub
enzym
would
yield
particular
percent
activ
exampl
ax
ic
inhibitor
concentr
requir
produc
inhibit
enzym
given
time
preincub
enzym
inhibitor
defin
condit
ph
temperatur
ionic
strength
ad
substrat
yield
eq
note
eq
k
ic
reciproc
relat
ic
time
depend
valid
calcul
ic
k
valu
pseudofirstord
kinet
obtain
valid
calcul
k
experiment
determin
fixedtim
ic
ic
alon
contain
inform
kinet
reaction
moreov
inhibitori
potenc
assess
measur
fixedtim
ic
valu
directli
essenti
report
time
preincub
along
primari
kinet
plot
ln
activ
remain
preincub
ach
variou
concentr
cpmo
time
interv
ad
substrat
note
extrapol
line
show
small
amount
zerotim
inhibit
indic
presenc
low
concentr
revers
michaelistyp
complex
b
secondari
kinet
plot
slope
k
primari
plot
vs
cpmo
concentr
slope
line
bimolecular
rate
constant
inhibit
k
min
kropp
richardson
concentr
ic
decreas
preincub
time
increas
exampl
ic
cpmo
hen
brain
microsom
ach
ph
min
min
nm
howev
choos
min
ic
decreas
nm
give
unwarr
impress
greater
potenc
prefer
assess
inhibitori
potenc
op
compound
esteras
kinet
rather
fixedtim
ic
valu
latter
easier
conceptu
richardson
thompson
richardson
even
greater
eas
conceptu
pic
recommend
navr
convert
ic
unit
pic
exampl
ic
nm
pic
pic
advantag
ic
exampl
ic
valu
unit
requir
expon
less
cumbersom
present
pic
data
moreov
pic
valu
intuit
ic
data
convey
rel
potenciesth
pic
directli
relat
inhibitori
potenc
addit
concentr
equal
space
log
scale
pic
confid
interv
standard
error
symmetr
log
scale
graphpad
howev
ic
time
preincub
state
along
pic
overal
prefer
use
pic
rather
ic
fixedtim
measur
inhibitori
potenc
kinet
determin
bimolecular
rate
constant
inhibit
k
prefer
either
fixedtim
valu
kropp
richardson
mortensen
et
al
strelow
certain
condit
k
k
compon
k
determin
exampl
primari
kinet
plot
pass
origin
secondari
plot
linear
may
appreci
concentr
michaelistyp
complex
consequ
k
term
must
explicitli
includ
combin
eq
yield
eq
eq
form
michaelismenten
equat
plot
k
vs
ax
hyperbol
shown
fig
hyperbol
plot
linear
shown
fig
doublereciproc
plot
magnifi
error
therefor
valu
k
k
ideal
determin
use
nonlinear
regress
eq
graphpad
ritchi
prvan
exampl
k
min
k
therefor
k
k
k
min
min
whenev
possibl
good
determin
k
k
valu
provid
inform
rate
phosphyl
affin
inhibitor
enzym
respect
wherea
k
alon
provid
inform
overal
potenc
inhibitor
enzym
aldridg
reiner
main
richardson
et
al
spontan
reactiv
describ
pseudofirstord
rate
constant
k
concentr
reactiv
h
essenti
constant
great
excess
spontan
reactiv
rate
constant
determin
preincub
enzym
concentr
inhibitor
produc
inhibit
within
short
interv
inhibitor
remov
dilut
prevent
ongo
inhibit
return
enzym
activ
measur
aliquot
time
interv
plot
ln
activ
vs
time
yield
straight
line
slope
correspond
halflif
calcul
via
eq
ach
phosphyl
op
compound
reactiv
quit
slowli
notabl
except
dimethylphosphorylach
reactiv
much
faster
diethylphosphoryl
enzym
exampl
rat
dimethylphosphorylach
k
min
h
wherea
rat
diethylphosphorylach
k
min
h
human
diethylphosphorylach
reactiv
similar
rate
rat
enzym
k
min
h
reactiv
acceler
strong
nucleophil
certain
oxim
fig
main
richardson
thompson
richardson
main
serin
esteras
inhibit
op
compound
contain
certain
labil
linkag
por
pnhr
undergo
reaction
age
wherebi
net
loss
rgroup
occur
yield
neg
charg
organophosphyl
group
still
coval
attach
activesit
serin
residu
enzym
rate
constant
age
denot
k
depend
esteras
inhibitor
age
proceed
via
n
mechan
eg
unimolecular
scission
ro
bond
yield
rh
n
process
eg
nucleophil
displac
robi
h
yield
roh
richardson
et
al
origin
inhibitor
contain
chiral
phosphoru
atom
age
speci
produc
either
mechan
becom
achir
neg
charg
deloc
two
oxygen
atom
render
equival
charg
phosphyl
group
stabil
hydrogen
bond
oxyanion
hole
enzym
neg
charg
repel
nucleophil
reactiv
masson
nachon
result
age
enzym
intract
reactiv
thu
k
determin
rapidli
inactiv
enzym
via
preincub
op
inhibitor
remov
dilut
inhibitor
prevent
ongo
inhibit
take
aliquot
time
interv
reactiv
ad
fluorid
ion
oxim
measur
residu
activ
richardson
age
progress
enzym
becom
increasingli
resist
reactiv
process
either
firstord
pseudofirstord
plot
ln
activ
restor
vs
linear
slope
reactiv
halflif
may
calcul
use
eq
substitut
k
k
exampl
k
human
ach
inhibit
dfp
min
h
contrast
k
human
ach
inhibit
paraoxon
k
min
h
diisopropylphosphoryl
enzym
age
faster
diethylphosphoryl
enzym
branch
alkyl
chain
favor
stabil
carboc
produc
n
displac
main
phenomenon
exploit
design
nerv
agent
soman
highli
branch
ageabl
pinacolyl
group
yield
age
approxim
min
shafferman
et
al
age
enzym
reactiv
oxim
rapid
age
follow
exposur
nerv
agent
preclud
treatment
antidot
thompson
richardson
previou
section
dealt
interact
op
inhibitor
serin
esteras
gener
although
mani
exampl
drawn
opach
interact
particular
therefor
section
discuss
ach
inhibit
age
briefli
mainli
context
toxic
exposur
suffici
high
dose
op
insecticid
nerv
agent
produc
cholinerg
toxic
via
inhibit
ach
central
andor
peripher
nervou
system
richardson
thompson
richardson
antiach
compound
term
cholinerg
physiolog
function
ach
termin
action
neurotransmitt
acetylcholin
ach
cholinerg
synaps
throughout
central
peripher
nervou
system
rel
high
level
inhibit
ach
result
accumul
excess
ach
consequ
postsynapt
muscarin
nicotin
ach
receptor
undergo
hyperstimul
follow
fatigu
ultim
result
muscl
paralysi
central
depress
respir
coma
death
note
regard
op
interact
serin
esteras
ach
inhibit
op
compound
contain
linkag
por
pnhr
undergo
age
postinhibitori
reaction
wherebi
net
loss
rgroup
occur
yield
neg
charg
organophosphyl
group
still
coval
attach
activesit
serin
residu
enzym
ach
inhibit
secondari
reaction
chang
type
sever
toxicityit
alter
kind
antidot
therapi
use
whether
age
occur
inhibit
ach
outcom
suffici
level
inhibit
samecholinerg
neurotox
age
phosphyl
ach
chang
type
treatment
avail
richardson
distinct
illustr
fig
counteract
excess
ach
result
inhibit
inhibit
plu
age
ach
atropin
given
attenu
muscarin
effect
dose
op
compound
high
enough
caus
convuls
seizur
anticonvuls
benzodiazepin
also
administ
addit
age
inhibit
ach
occur
oxim
hydroxyimino
methyl
aldoxim
methyl
given
reactiv
inhibit
enzym
fig
thompson
richardson
howev
age
occur
ineffect
two
reason
neg
charg
age
phosphyl
group
repel
nucleophil
oxim
age
phosphyl
group
strongli
stabil
hydrogen
bond
region
activ
site
enzym
call
oxyanion
hole
masson
nachon
quinn
et
al
howev
recent
report
suggest
might
possibl
resurrect
age
ach
use
quinon
methid
precursor
qmp
realkyl
age
enzym
render
reactivat
compound
also
serv
reactiv
franjesiv
et
al
zhuang
et
al
toxicolog
consequ
ach
inhibit
age
upper
reaction
ach
shown
red
organophosph
first
yield
inhibit
enzym
result
cholinerg
toxic
treatabl
atropin
inhibit
enzym
age
reactiv
possibl
also
administ
fig
age
occur
ach
still
inhibit
reactiv
therefor
ineffect
treatment
limit
atropin
alon
although
anticonvuls
could
given
convuls
present
lower
reaction
organophosphin
yield
inhibit
enzym
result
cholinerg
toxic
age
occur
stabil
carbonphosphoru
bond
atropin
given
treatment
note
age
ach
depict
proceed
via
n
scission
yield
rh
r
substitut
unsubstitut
aryl
alkyl
group
oxim
oxygen
attack
phosphoru
atom
unag
organophosphoryl
moieti
coval
attach
activesit
serin
ach
displac
reactiv
ach
produc
phosphoryl
oxim
compound
ineffect
inhibit
enzym
undergon
age
reaction
thompson
richardson
r
r
substitut
unsubstitut
alkyl
aryl
group
may
differ
unlik
cholinerg
toxic
depend
upon
inhibit
critic
amount
nervou
system
ach
opidn
appear
requir
inhibit
least
nervou
system
nte
along
age
inhibit
enzym
note
op
compound
produc
opidn
said
neuropath
consequ
inhibit
nte
age
vs
nonag
inhibitor
shown
fig
possibl
opidn
aris
insidi
neuropath
compound
potent
nte
inhibitor
poor
ach
inhibitor
accordingli
compound
trigger
axon
degener
well
dose
requir
elicit
cholinerg
toxic
richardson
richardson
et
al
age
process
inhibit
nte
similar
inhibit
achea
postinhibitori
loss
secondari
leav
group
op
moieti
result
format
neg
charg
organophosphyl
group
coval
attach
activesit
serin
residu
enzym
toxicolog
consequ
nte
inhibit
age
upper
reaction
nte
shown
blue
organophosph
yield
inhibit
enzym
opidn
result
age
occur
current
specif
treatment
opidn
lower
reaction
organophosphin
produc
inhibit
enzym
age
occur
stabil
carbonphosphoru
bond
opidn
protect
subsequ
exposur
neuropath
op
compound
note
age
nte
thought
proceed
via
n
reaction
h
rgroup
displac
roh
moreov
neuropath
nte
inhibitor
age
occur
within
minut
preclud
postinhibitori
treatment
reactiv
johnson
kropp
et
al
richardson
makhaeva
r
substitut
unsubstitut
alkyl
aryl
group
may
differ
howev
rather
proceed
via
n
mechan
age
nte
inhibit
neuropath
op
compound
thought
occur
n
mechan
organophosph
organophosphon
age
valu
rang
min
compound
rgroup
straightchain
eg
nbutyl
slightli
branch
eg
isopropyl
johnson
nte
inhibit
phosphoramid
mipafox
appear
age
instantan
possibl
deproton
kropp
et
al
ageabl
rgroup
organophospyl
nte
highli
branch
pinacolyl
moieti
age
lengthen
h
lend
support
propos
n
mechan
age
organophosphyl
nte
given
rel
rapid
rate
age
nte
inhibit
neuropath
op
compound
age
ratelimit
step
delay
week
inhibit
nte
onset
clinic
sign
opidn
likewis
inhibit
nte
ratelimit
step
given
inhibit
experiment
anim
occur
within
hour
dose
wijeyesaker
richardson
sporad
case
opidn
report
sinc
nineteenth
centuri
largest
epidem
took
place
unit
state
earli
toward
end
era
prohibit
product
import
transport
sale
alcohol
beverag
ban
davi
richardson
period
extract
jamaican
ginger
colloqui
call
jake
use
wide
mean
obtain
ethyl
alcohol
presum
potabl
howev
certain
stock
extract
adulter
solvent
contain
tri
phosphat
triorthocresyl
phosphat
tocp
also
known
triorthotolyl
phosphat
totp
metabol
neuropath
nte
inhibitor
orthocresyl
cbdp
fig
carletti
et
al
reinen
et
al
consumpt
tocpcontamin
mixtur
throughout
countri
result
seri
largescal
outbreak
paralysi
known
variou
name
includ
jake
leg
jake
walk
ginger
paralysi
morgan
tulloss
smith
et
al
b
number
afflict
individu
never
accur
determin
although
figur
high
cite
morgan
bulletin
us
veteran
administr
state
offici
report
case
bevi
articl
indic
accord
estim
bureau
prohibit
true
number
least
sinc
smaller
outbreak
opidn
follow
exposur
tocp
usual
contamin
cook
oil
report
sever
countri
includ
germani
world
war
ii
karczmar
morocco
glynn
smith
spald
sri
lanka
senanayak
format
cbdp
tocp
nte
inhibit
propos
altern
age
pathway
tocp
metabol
cytochrom
hydroxyl
intermedi
undergo
intern
cycliz
elimin
cresyl
group
form
activ
nte
inhibitor
cbdp
inhibit
nte
could
undergo
age
via
propos
altern
pathway
net
loss
saligenin
cresyl
group
age
reaction
could
stop
first
elimin
proceed
sequenti
loss
cresyl
saligenin
yield
final
age
product
phosphat
group
coval
attach
nte
activ
site
serin
residu
carletti
et
al
reinen
et
al
isom
cbdp
shown
enantiom
react
faster
catalyt
domain
nte
wu
casida
howev
yet
known
initi
cbdpnte
adduct
retain
invert
racem
stereochemistri
age
product
achir
owe
deloc
neg
charg
two
equival
oxygen
atom
nte
shown
blue
recent
time
report
opidn
case
worldwid
infrequ
usual
associ
fail
suicid
attempt
involv
ingest
op
insecticid
although
accident
occup
exposur
also
involv
jokanovi
c
et
al
lotti
moretto
global
declin
opidn
case
due
part
increasingli
stringent
regul
op
compound
use
nte
assay
screen
op
compound
neuropath
potenti
nevertheless
continu
studi
neuropath
op
compound
opidn
nte
warrant
sever
reason
exampl
op
compound
continu
employ
numer
applic
use
flame
retard
increas
owe
phaseout
class
agent
polybromin
diphenyl
ether
pbde
ospina
et
al
moreov
anticholinesteras
op
compound
remain
import
agent
chemic
warfar
terror
figueiredo
et
al
neuropath
op
compound
pose
latent
threat
regard
richardson
et
al
exposur
op
compound
also
continu
implic
etiolog
variou
condit
solid
research
need
resolv
issu
causat
vs
correl
amid
complex
controversi
disord
includ
aerotox
syndrom
carletti
et
al
hageman
et
al
gulf
war
ill
michalovicz
et
al
thyroid
endocrin
disrupt
yang
et
al
type
diabet
obes
czajka
et
al
howev
arguabl
compel
justif
nte
research
embodi
intrigu
scientif
question
concern
mechan
axon
degener
follow
chang
structur
andor
function
nte
brought
chemic
exposur
andor
genet
mutat
hufnagel
et
al
kmoch
et
al
read
et
al
richardson
et
al
sunderhau
et
al
b
histori
nte
import
histori
goeth
wise
assert
die
geschicht
der
wissenschaft
die
wissenschaft
selbst
sei
histori
scienc
scienc
goeth
santayana
famous
observ
rememb
past
condemn
repeat
santayana
accordingli
understand
scienc
nte
avoid
reinvent
alreadi
devis
prudent
retrac
stori
discoveri
conceptu
evolut
stori
began
clever
chemic
think
import
intrigu
toxicolog
problem
long
applic
modern
molecular
biolog
bioinformat
gave
us
current
view
fascin
protein
moreov
still
much
learn
nte
spirit
past
prologu
shakespear
histori
like
provid
valuabl
clue
help
us
draw
blueprint
solv
mysteri
futur
johnson
train
chemist
accustom
solv
intract
problem
come
mrc
former
mentor
would
repeatedli
exhort
challeng
johnson
wo
nt
workbut
tri
mk
johnson
person
commun
thu
forearm
johnson
accustom
undertak
experi
other
would
consid
imposs
difficult
fruitless
johnson
join
mrc
toxicolog
unit
prime
favor
leadership
attitud
imagin
help
ensur
success
work
undertak
unit
directorship
john
barn
physician
commit
foster
mechanist
research
among
mani
notabl
achiev
conduct
first
toxicolog
test
penicillin
shortli
onset
wwii
witschi
johnson
report
directli
wn
aldridg
highli
respect
biochemist
charg
biochem
mechan
section
time
aldridg
formul
unifi
thesi
much
life
workth
notion
enzym
inhibitor
resembl
substrat
aldridg
alreadi
done
pioneer
work
understand
acut
cholinerg
effect
op
compound
studi
kinet
bind
ach
somewhat
later
aldridg
collabor
elsa
reiner
visit
scientist
institut
medic
research
zagreb
produc
book
enzym
inhibitor
substrat
interact
esteras
ester
organophosphoru
carbam
acid
aldridg
reiner
regard
one
great
classic
mechanist
toxicolog
witschi
lock
aldridg
kept
staff
head
right
direct
make
import
discoveri
continu
remind
question
ask
go
anomali
expect
answer
seldom
tell
us
anyth
interest
pursu
unexpect
lead
breakthrough
w
n
aldridg
person
commun
barn
aldridg
establish
guid
philosophi
mrc
toxicolog
unit
defin
way
scientist
would
choos
research
problem
two
main
criteria
first
problem
refer
toxicolog
unit
matter
practic
public
health
medic
import
usual
aris
occup
exposur
second
problem
intrins
scientif
interest
show
promis
someth
whose
intens
unrestrict
studi
would
yield
mechanist
insight
thu
advanc
scienc
toxicolog
witschi
lock
principl
becom
offici
mrc
doctrin
evidenc
johnson
quotat
mrc
handbook
review
articl
opidn
aim
toxicolog
unit
establish
basic
concept
necessari
explain
molecular
level
mechan
toxic
chemic
physic
injuri
johnson
sever
scientist
came
work
toxicolog
unit
associ
wwii
chemic
defenc
establish
porton
one
chief
concern
understand
acut
cholinerg
toxic
op
nerv
agent
order
develop
prophylact
drug
antidot
although
delay
neurotox
op
compound
well
known
sinc
major
episod
earli
aspect
op
toxic
associ
singl
noncholinerg
compound
triocresyl
phosphat
tocp
bevi
smith
et
al
b
fison
plc
three
worker
involv
pilot
plant
product
new
insecticid
candid
call
mipafox
present
acut
cholinerg
toxic
bidstrup
et
al
two
three
affect
individu
admit
hospit
treatment
ultim
discharg
subsequ
two
patient
develop
delay
neurotox
close
resembl
poison
tocp
mipafox
incid
demonstr
op
compound
structur
dissimilar
tocp
activ
metabolit
cbdp
could
produc
op
delay
neurotox
fig
episod
likewis
rais
concern
form
insidi
perman
debilit
toxic
could
extend
op
compoundseith
alreadi
use
develop
futur
perfect
problem
taken
mrc
toxicolog
unit
arisen
industri
exposur
clearli
medic
public
health
import
intrigu
scientif
mysteri
whose
investig
held
promis
yield
mechanist
insight
neurotox
neurodegen
diseas
consequ
research
start
unit
investig
mechan
op
delay
neurotox
barn
togeth
aldridg
e
poulsen
laid
foundat
johnson
ultim
discoveri
initi
search
suitabl
target
hen
brain
aldridg
aldridg
barn
b
poulsen
aldridg
time
earlier
work
establish
adult
hen
vulner
anim
model
choic
opidn
studi
smith
et
al
rat
mice
immatur
chicken
appear
resist
adult
rooster
vulner
less
readili
avail
far
less
docil
hen
ach
butyrylcholinesteras
bche
also
rule
potenti
target
opidn
cavanagh
davison
smith
lilli
poulsen
aldridg
reason
neuropath
op
compound
coval
bind
unknown
serin
esteras
hen
brain
capabl
hydrolyz
substrat
phenyl
phenylacet
ppa
phenyl
phenylpropion
ppp
whose
structur
somewhat
resembl
cbdp
cyclic
saligenin
phosphat
activ
metabolit
tocp
fig
initi
enzym
activ
found
clear
correl
inhibit
delay
neurotox
lack
retrospect
earli
experi
come
tantalizingli
close
defin
relev
esteras
activ
hamper
rel
lack
sensit
warburg
manometr
assay
method
requir
measur
small
volum
co
ga
liber
bicarbon
buffer
reaction
acid
produc
enzymat
cleavag
ester
substrat
true
signal
lost
nois
year
later
poulsen
lament
narrow
miss
identifi
nte
glad
johnson
success
e
poulsen
person
commun
undaunt
initi
failur
johnson
convinc
theori
select
bind
correct
use
sensit
radiometr
approach
employ
p
diisopropylphosphorofluorid
dfp
radiolabel
neuropath
analogu
mipafox
abl
identifi
portion
label
site
hen
brain
tissu
block
neuropath
mipafox
block
nonneuropath
tetraethylpyrophosph
tepp
aldridg
et
al
johnson
johnson
furthermor
abl
quantifi
decreas
radiolabel
phosphoryl
site
vitro
preincub
hen
brain
homogen
neuropath
op
compound
ex
vivo
brain
homogen
hen
dose
neuropath
op
compound
johnson
return
aldridg
theori
site
identifi
differenti
incub
select
inhibitor
radiolabel
like
serin
esteras
first
abl
show
radiolabel
site
could
block
preincub
hen
brain
homogen
carboxyl
acid
ester
ppa
studi
ppa
hydrolas
activ
use
colorimetr
assay
show
resist
inhibit
nonneuropath
op
compound
tepp
paraoxon
portion
residu
activ
sensit
inhibit
neuropath
compound
mipafox
johnson
c
rel
small
proport
mipafoxsensit
paraoxonresist
activ
came
known
first
neurotox
esteras
johnson
johnson
later
neuropathi
target
esteras
among
journal
circul
johnson
desk
mrc
librari
analyt
biochemistri
reflect
deep
appreci
fact
scientif
advanc
requir
dreami
qualiti
live
imagin
practic
progress
depend
critic
method
exampl
fond
tell
cowork
lab
despit
astonish
success
lowri
protein
assay
lowri
et
al
highli
cite
scientif
paper
time
aksn
et
al
still
perfect
method
quantifi
protein
crude
mixtur
johnson
predict
fame
fortun
await
investig
could
devisenot
better
mousetrapbut
better
procedur
lowri
method
assay
protein
content
biolog
sampl
live
privat
britain
impos
wwii
johnson
also
keen
econom
whenev
possibl
made
good
use
admir
broad
knowledg
techniqu
along
desir
get
spars
resourc
least
two
way
first
recogn
energet
electron
emit
p
emit
visibl
light
pass
dielectr
medium
water
cherenkov
effect
cherenkov
devis
method
measur
p
radiat
use
standard
scintil
counter
simplifi
economi
requir
addit
chemic
scintil
elabor
sampl
prepar
johnson
second
order
simplifi
increas
sensit
esteras
assay
compar
cumbersom
rel
insensit
warburg
manometr
method
johnson
sought
develop
colorimetr
assay
realiz
substrat
choic
ppa
would
hydrolyz
esteras
phenylacet
acid
phenol
reach
back
retriev
report
quantit
colorimetr
approach
determin
concentr
phenol
fungicid
fabric
gottlieb
marsh
adapt
use
esteras
assay
substrat
ultim
chang
ppa
phenyl
valer
pv
principl
assay
remain
see
fig
johnson
kayyali
et
al
interest
note
johnson
first
publish
accountin
abstract
formof
asyet
unnam
esteras
activ
inadvert
put
togeth
right
word
differ
mean
phenyl
ester
acid
ppa
acid
ppp
structur
analog
neurotox
esteras
inhibitor
phenylsaligenin
phosphat
johnson
emphasi
ad
abstract
johnson
refer
fact
esteras
inhibitor
neurotox
term
use
context
indic
compound
neuropath
ie
capabl
produc
opidn
appear
may
time
unconsci
christen
nte
initi
name
neurotox
esteras
first
full
paper
refer
neurotox
esteras
johnson
johnson
maintain
provision
statu
name
alway
put
quotat
mark
around
soon
thereaft
urg
one
us
rjr
postdoc
lab
johnson
becam
convinc
new
entiti
fulli
fledg
allow
name
stand
undiminish
would
say
invert
comma
johnson
b
c
next
year
privat
correspond
convers
scientif
confer
number
scientist
express
confus
name
johnson
enzym
say
nomenclatur
suggest
esteras
neurotox
seem
unten
premis
protein
sure
must
normal
physiolog
function
would
therefor
neurotox
right
johnson
acquiesc
logic
began
refer
nte
neuropathi
target
esteras
new
name
seem
descript
role
esteras
site
end
preincub
interv
substrat
pv
ad
time
incub
period
nte
esteras
hydrolyz
pv
valer
acid
phenol
colorimetr
reagent
aap
ad
along
k
fe
cn
form
plumr
phenolaap
chromophor
absorb
b
c
read
nm
convert
molar
unit
phenol
form
calibr
phenol
standard
nte
activ
proport
ac
ab
bc
absorb
requir
includ
illustr
purpos
blank
selfcorrect
good
practic
includ
tissu
blank
check
nonenzymat
gener
phenol
reagent
blank
check
decomposit
substrat
phenol
valer
acid
johnson
kayyali
et
al
structur
neuropath
inhibitor
mipafox
nonneuropath
inhibitor
paraoxon
shown
fig
structur
phenolaap
chromophor
deduc
correctli
gottlieb
marsh
later
confirm
pf
jone
k
e
johnson
use
proton
nmr
jone
johnson
aapphenol
reaction
come
wide
use
numer
assay
employ
colorimetr
electrochem
endpoint
varadaraju
et
al
attack
neuropath
op
compound
produc
axonopathi
moreov
refresh
monik
preserv
set
initi
origin
use
protein
paraphras
proclam
continu
echo
centuri
british
loyal
subject
kingdom
concert
pass
access
monarchsnt
dead
long
live
nte
sir
rudolph
peter
renown
biochemist
oxford
led
effort
wwii
develop
british
antilewisit
bal
effect
antidot
organoarsen
chemic
warfar
agent
lewisit
peter
et
al
subsequ
work
show
toxic
fluoroacet
due
biotransform
fluorocitr
gener
concept
lethal
synthesi
power
idea
major
influenc
toxicolog
think
equal
potent
notion
biochem
lesion
term
coin
refer
initi
molecular
perturb
chain
event
lead
eventu
tissu
degener
histopatholog
chang
could
detect
gavrilescu
peter
peter
peter
concept
lethal
synthesi
biochem
lesion
clearli
impact
johnson
launch
theori
neurotox
esteras
semin
paper
titl
primari
biochem
lesion
lead
delay
neurotox
effect
organophosphoru
ester
johnson
emphasi
ad
public
johnson
recount
key
observ
inhibitor
nte
produc
opidn
howev
nonneuropath
inhibitor
biolog
inertthey
protect
chicken
adult
hen
opidn
subsequ
challeng
neuropath
nte
inhibitor
johnson
lauweri
critic
molecular
differ
two
type
inhibitor
nonneuropath
protect
compound
incap
form
age
nte
wherea
neuropath
op
compound
capabl
produc
age
ntea
protein
coval
link
neg
charg
organophosphyl
group
thu
perfect
exampl
lethal
synthesi
give
rise
biochem
lesion
johnson
colleagu
establish
concert
molecular
reaction
inhibit
age
nte
take
place
within
hour
dose
well
histolog
lesion
clinic
sign
opidn
appear
typic
week
later
johnson
johnson
johnson
b
c
johnson
makhaeva
et
al
present
specif
chemic
modif
nte
still
earliest
known
stage
pathogenesi
opidn
therebi
regard
initi
event
nevertheless
yet
elucid
step
involv
ensu
axon
degener
determin
organophosphyl
age
nte
trigger
degen
chang
howev
import
clue
pathogenesi
uncov
jb
cavanagh
distinguish
neuropathologist
institut
neurolog
london
work
close
scientist
mrc
toxicolog
unit
throughout
career
cavanagh
cowork
help
establish
opidn
primari
axonopathi
demyelin
secondari
process
especi
affect
long
axon
larg
diamet
peripher
nerv
spinal
cord
tract
addit
determin
ach
bche
involv
observ
neuropath
op
compound
act
like
chemic
scalpel
produc
chemic
transect
axon
caus
region
distal
initi
lesion
undergo
wallerian
degener
addit
cavanagh
note
lesion
resembl
produc
thiamin
defici
thought
decreas
energi
metabol
lead
degener
distal
axonsth
region
neuron
distant
cell
bodi
bouldin
cavanagh
b
cavanagh
cavanagh
holland
return
later
observ
suggest
model
opidn
wallerian
degener
johnson
inspir
scientist
around
gift
instil
other
fascin
nte
research
frequent
attend
intern
confer
made
visit
laboratori
around
world
take
keen
interest
mani
peopl
met
activ
result
attract
visit
worker
mrc
toxicolog
unit
would
later
take
nte
research
home
institut
addit
would
make
point
introduc
one
scientist
anoth
therebi
engend
new
fruit
collabor
field
sinc
incept
johnson
nte
assay
enjoy
number
rel
minor
improv
correl
ehrich
johnson
johnson
richardson
kayyali
et
al
howev
still
base
differenti
inhibit
hydrolas
activ
toward
artifici
ester
substrat
eg
phenyl
valer
neuropath
eg
mipafox
nonneuropath
eg
paraoxon
inhibitor
detect
differ
product
format
eg
phenol
product
colorimetr
electrochem
sigolaeva
et
al
differenti
assay
requir
cell
tissu
contain
esteras
addit
nte
inhibit
paraoxon
mipafox
still
leav
residu
hydrolas
activ
resist
inhibitor
principl
nte
assay
shown
fig
nte
assay
made
possibl
screen
op
compound
quantit
assess
neuropath
potenti
use
vitro
prepar
ex
vivo
follow
dose
experiment
anim
soon
discov
appar
threshold
inhibit
presum
concomit
age
nervou
system
nte
activ
order
precipit
opidn
johnson
moreov
nte
inhibit
threshold
found
appli
chronic
dose
well
acut
dose
regimen
shown
sever
independ
experi
carri
dose
threshold
opidn
induc
tocp
given
daili
day
barn
henschler
smith
et
al
use
potent
neuropath
op
compound
monoocresyl
diphenyl
phosphat
mocp
lotti
johnson
found
daili
dose
mgkgday
week
result
chronic
inhibit
brain
spinal
cord
nte
respect
clinic
sign
opidn
howev
opidn
could
precipit
superimpos
singl
high
dose
mgkg
increas
repeat
dose
mgkgday
result
elev
nte
inhibit
experi
also
demonstr
effect
inhibit
nte
threshold
cumul
compound
antiach
well
antint
activ
possibl
calcul
rel
inhibitori
potenc
rip
defin
ratio
bimolecular
rate
constant
inhibit
k
enzym
altern
rip
defin
use
fixedtim
ic
valu
concentr
inhibitor
requir
inhibit
enzym
activ
given
time
preincub
inhibitor
enzym
ic
k
reciproc
see
eq
rip
base
ic
valu
reciproc
ratio
base
k
valu
shown
eq
defin
way
rip
cholinerg
toxic
compound
like
produc
cholinerg
toxic
death
produc
opidn
kropp
richardson
lotti
johnson
richardson
note
studi
prefer
emphas
neuropath
potenti
op
compound
defin
rip
potenc
nte
numer
eq
defin
reciproc
manner
rip
opidn
compound
like
produc
opidn
cholinerg
toxic
earlier
year
nte
research
mrc
much
import
sar
data
accumul
nte
inhibitor
made
possibl
chemic
industri
suppli
johnson
lab
hundr
op
compound
nte
test
work
undertaken
base
upon
understand
data
could
freeli
publish
open
literatur
davi
et
al
johnson
johnson
b
c
result
also
made
possibl
quantifi
differ
potenc
among
nte
inhibitor
thu
give
rise
quantit
sar
qsar
data
sar
qsar
inform
prove
quit
use
make
predict
neuropath
potenti
given
compound
exampl
result
hen
brain
nte
assay
hour
dose
enabl
follow
conclus
drawn
although
extens
sar
qsar
studi
nte
inhibitor
provid
partial
support
theori
inhibit
age
nte
requir
precipit
opidn
convinc
evid
came
experi
show
pretreat
nonag
nte
inhibitor
protect
opidn
subsequ
challeng
ageabl
nte
inhibitor
much
earli
work
protect
opidn
summar
excel
review
carrington
semin
report
protect
show
phenyl
benzylcarbam
inhibit
hen
brain
nte
vitro
vivo
johnson
lauweri
howev
carbamoyl
enzym
undergo
rel
rapid
fig
gener
structur
class
b
nte
inhibitor
type
inhibitor
includ
phosphat
phosphon
phosphoramid
type
inhibitor
capabl
age
inhibit
nervou
system
nte
result
opidn
type
b
inhibitor
includ
phosphin
sulfon
carbam
type
b
inhibitor
age
inhibit
nervou
system
nte
result
opidn
howev
inhibit
nervou
system
nte
nonag
inhibitor
confer
protect
opidn
subsequ
administr
otherwis
neuropath
dose
type
inhibitor
rgroup
substitut
unsubstitut
alkyl
aryl
moieti
phosphoramid
carbam
r
also
hydrogen
x
primari
leav
group
case
spontan
reactiv
halflif
vivo
hour
postdos
reactiv
fortuit
permit
determin
doserespons
time
cours
protect
thu
pretreat
hen
phenyl
benzylcarbam
confer
complet
protect
clinic
histopatholog
manifest
opidn
challeng
dose
delay
neurotoxic
dfp
long
level
nte
inhibit
produc
carbam
time
dfp
challeng
given
posit
control
pretreat
dmso
vehicl
develop
sever
opidn
dfp
administr
parallel
experi
p
dfp
show
carbam
pretreat
affect
entri
dfp
brain
followup
studi
show
protect
opidn
dfp
also
confer
pretreat
phenyl
nbenzylnmethyl
carbam
phenyl
nbutylcarbam
phenylmethanesulfonyl
fluorid
pmsf
nbutanesulfonyl
fluorid
johnson
doserespons
time
cours
experi
demonstr
protect
requir
least
inhibit
nte
time
challeng
dose
dfp
administ
wherea
dose
dfp
alon
requir
inhibit
nte
produc
opidn
prolong
inhibit
nte
level
week
pmsf
inhibit
nbutanesulfonyl
fluorid
produc
opidn
final
protect
pmsf
opidn
dfp
could
block
pretreat
phenyl
benzylcarbam
next
johnson
found
phosphin
eg
dinbutylphosphin
dinpentylphosphin
dinpentylphosphin
high
structur
similar
neuropath
phosphat
phosphon
inhibit
nte
neuropath
johnson
upon
test
compound
abil
protect
opidn
induc
dfp
found
complet
protect
afford
day
match
time
brain
nte
inhibit
fall
thu
suggest
threshold
inhibit
age
brain
nte
order
precipit
opidn
subsequ
experi
laboratori
confirm
johnson
observ
protect
opidn
includ
studi
time
cours
protect
pmsf
opidn
induc
tocp
hen
carrington
aboudonia
well
pmsf
protect
intraarteri
produc
unilater
dfpinduc
opidn
cat
drakontid
baker
hen
caroldi
et
al
moreov
import
conclus
unilater
experi
opidn
could
produc
direct
effect
op
compound
axon
wherea
rat
resist
clinic
sign
opidn
exhibit
histopatholog
find
axon
degener
follow
administr
neuropath
op
compound
accordingli
veronesi
padilla
abl
show
protect
pmsf
spinal
cord
lesion
produc
mipafox
rat
likewis
protect
confer
thiocarbam
molin
opidn
induc
dinbutyl
dichlorvo
dbdcv
rat
well
hen
moretto
et
al
work
johnson
lab
extend
protect
agent
hen
inhibitori
nonag
isom
insecticid
epn
protect
opidn
opposit
epn
isom
inhibit
nte
age
johnson
read
partial
protect
observ
pretreat
hen
nerv
agent
soman
challeng
dfp
johnson
et
al
somaninhibit
hen
brain
nte
found
age
neglig
owe
extrem
high
acut
cholinerg
toxic
soman
nte
data
singl
anim
group
possibl
assess
accur
level
nonag
nte
somanpredos
hen
final
johnson
found
phosphin
identifi
earlier
nonneuropath
nte
inhibitor
protect
neuropath
op
compound
also
shortcom
nteopidn
studi
addit
difficult
synthes
phosphin
exhibit
high
acut
cholinerg
toxic
chemic
instabl
ultim
discov
phenyl
dinpentylphosphin
easi
synthes
display
high
potenc
nte
high
chemic
stabil
low
potenc
ach
moreov
new
phosphin
confer
complet
protect
clinic
histopatholog
sign
opidn
induc
dfp
challeng
either
day
prophylact
treatment
johnson
read
johnson
et
al
cn
pope
padilla
demonstr
nonag
nte
inhibitor
protect
opidn
given
prior
dose
neuropath
age
inhibitorwhen
order
dose
revers
nonag
nte
inhibitor
potenti
neuropath
effect
age
inhibitor
pope
padilla
surpris
phenomenon
studi
lotti
colleagu
chang
name
public
potenti
promot
terminolog
base
absenc
clinic
sign
opidn
follow
dose
age
inhibitor
nte
ie
initi
vs
appear
clinic
sign
opidn
follow
dose
initi
subsequ
dose
nonag
inhibitor
nte
ie
promot
lotti
moretto
potenti
actual
notic
earli
experi
design
demonstr
protect
afford
pmsf
mipafoxinduc
spinal
cord
lesion
rat
note
although
rat
mice
highli
resist
clinic
manifest
opidn
express
nervou
system
uniprot
c
develop
axon
lesion
particularli
evid
dorsal
column
spinal
cord
respons
treatment
neuropath
op
compound
lapadula
et
al
padilla
veronesi
veronesi
veronesi
padilla
pmsf
protect
rat
axonopathi
given
h
prior
mipafox
protect
absent
pmsf
given
day
mipafox
contrast
mipafox
given
h
pmsf
exacerb
axonopathi
howev
author
note
lesion
exacerb
case
differ
somewhat
appear
distribut
produc
mipafox
alon
event
experi
ad
support
johnson
theori
opidn
requir
inhibit
age
nte
first
report
potenti
opidn
nonag
inhibitor
nte
specif
basi
potenti
promot
opidn
elucid
view
fact
potenti
promot
delay
recoveri
nerv
crush
plausibl
gener
explan
involv
notion
interfer
mechan
repair
axon
injuri
lotti
addit
although
first
report
potentiationpromot
indic
effect
compound
nte
inhibitor
subsequ
work
lotti
colleagu
strongli
suggest
target
promotionpotenti
nte
lotti
lotti
moretto
moretto
et
al
moretto
et
al
discoveri
character
nte
activ
circul
lymphocyt
platelet
bertoncin
et
al
bleecker
et
al
dudek
richardson
maroni
bleecker
made
possibl
use
blood
sampl
biomonitor
exposur
neuropath
op
compound
lotti
et
al
schwab
richardson
advent
electrochem
biosensor
nte
activ
could
determin
whole
blood
makhaeva
et
al
sigolaeva
et
al
thu
obviat
need
isol
leukocyt
fraction
prior
analysi
moreov
biosensor
assay
permit
realtim
detect
nte
activ
could
extend
simultan
assay
sever
esteras
kohli
et
al
sigolaeva
et
al
differ
op
compound
vari
inhibitori
potenc
differ
esteras
differenti
inhibit
creat
esteras
profil
given
inhibitor
serv
predict
type
toxic
therapeut
effect
exert
makhaeva
et
al
decad
research
nte
sinc
discoveri
studi
focus
inhibit
age
esteras
function
associ
event
opidn
develop
biomark
biosensor
exposur
neuropath
op
compound
makhaeva
et
al
b
richardson
et
al
rel
recent
investig
expand
includ
noncatalyt
region
protein
factor
may
regul
hydrolas
function
turnov
interact
protein
nte
knockout
silenc
nte
mutat
associ
diseas
huang
et
al
hufnagel
et
al
sogorb
et
al
synofzik
schule
synofzik
et
al
synofzik
et
al
new
develop
cours
result
engag
new
gener
research
along
earlier
day
continu
explor
nte
appli
modern
tool
molecular
biolog
bioinformat
comput
molecular
model
mani
advanc
understand
nte
stem
discoveri
sw
swiss
chees
drosophila
orthologu
human
nte
name
vacuol
appear
fruit
fli
brain
aris
certain
mutat
sw
gene
encod
sw
protein
kretzschmar
et
al
sunderhau
et
al
b
earli
mk
johnson
phase
retir
move
mrc
toxicolog
unit
carshalton
univers
leicest
import
new
develop
nte
research
realiz
includ
affin
purif
clone
sequenc
human
protein
glynn
glynn
et
al
glynn
et
al
lush
et
al
screen
human
brain
cdna
librari
yield
first
report
sequenc
nte
clone
compris
amino
acid
catalyt
center
defin
locat
within
hydrophob
region
lush
et
al
sequenc
categor
uniprot
regard
canon
nte
sequenc
isoform
aris
altern
splice
identifi
thu
far
uniprot
canon
compris
residu
activesit
serin
residu
note
nation
center
biotechnolog
inform
ncbi
refer
sequenc
isoforma
accessionvers
number
ncbi
throughout
remaind
chapter
except
otherwis
indic
number
canon
sequenc
use
also
note
despit
knowledg
sequenc
domain
nte
threedimension
structur
still
determin
experiment
patatinhomolog
nte
pnte
analog
drosophila
homologu
sw
wentzel
et
al
potenti
fourth
type
domain
pka
bind
pkab
propos
resid
tm
domain
specif
site
interest
includ
g
nglycosyl
site
ps
pt
phosphoryl
site
serin
threonin
respect
activ
site
residu
catalyt
domain
uniprot
pnte
homolog
domain
glynn
wijeyesaker
et
al
recent
drosophila
nte
orthologu
sw
fourth
domain
describ
bind
catalyt
subunit
protein
kinas
pka
bettencourt
da
cruz
et
al
sunderhau
et
al
b
refer
region
pkab
follow
subsect
briefli
discuss
current
state
knowledg
domain
well
subcellular
local
nte
highlight
area
new
research
need
address
gap
knowledg
understand
note
protein
domain
often
precis
demarc
residu
assign
given
domain
sometim
overlap
adjoin
domain
residu
assign
domain
may
differ
somewhat
data
sourc
eg
uniprot
ncbi
ntermin
tm
domain
nte
anchor
protein
cytoplasm
face
endoplasm
reticulum
er
consist
natur
mammalian
transmembran
domain
structur
predict
span
residu
nte
case
tm
region
consist
residu
residu
local
within
er
lumen
remain
residu
cytoplasm
side
uniprot
interestingli
analysi
primari
sequenc
nte
suggest
presenc
nlink
glycosyl
site
residu
absent
denot
g
fig
virtual
noth
known
possibl
role
potenti
nlink
glycosyl
site
howev
erfold
protein
site
serv
direct
nascent
polypeptid
calnexincalreticulin
chaperon
cycl
lamriben
et
al
wijeyesaker
et
al
thu
role
glycanbind
er
chaperon
bind
promot
fold
subset
nte
molecul
repres
intrigu
area
investig
cnb
domain
nte
encompass
follow
residu
number
uniprot
wijeyesaker
et
al
canon
number
domain
contain
within
follow
residu
fig
uniprot
cyclic
nucleotid
cyclic
amp
camp
cyclic
gmp
cgmp
play
crucial
role
second
messeng
transduc
signal
varieti
cellular
signal
system
throughout
life
form
rang
bacteria
human
gancedo
thu
presenc
tandem
seri
put
cnb
domain
within
ntermin
local
nte
suggest
region
may
play
role
regul
hydrolas
activ
current
domain
organ
nte
first
publish
wijeyesaker
et
al
littl
known
structur
function
three
cnb
domain
inde
previou
decad
singl
studi
hint
domain
might
vestigi
remnant
incap
engag
cyclic
nucleotid
dremier
et
al
nevertheless
unwil
accept
appar
cnb
region
could
devoid
purpos
exist
three
domain
suggest
possibl
nte
requir
exquisit
tunabl
control
accordingli
use
homolog
model
carri
preliminari
molecular
dock
simul
found
cyclic
nucleotid
camp
cgmp
dock
put
bind
pocket
three
cnb
domain
favor
free
energi
bind
sjw
rjr
unpublish
data
recent
eleg
experi
drosophila
shown
certain
mutat
sw
fruitfli
orthologu
nte
produc
neurodegen
diseas
disrupt
phospholipid
homeostasi
rescu
express
wildtyp
nte
fli
sunderhau
et
al
howev
express
nte
contain
diseasecaus
mutat
either
catalyt
domain
cnb
domain
suppress
neurolog
deficit
restor
lipid
homeostasi
find
provid
support
two
import
conclus
disrupt
catalyt
function
nte
suffici
produc
neurodegener
cnb
domain
particip
regul
nte
catalyt
activ
far
bestcharacter
aspect
nte
hydrolas
activ
resid
catalyt
domain
residu
uniprot
structur
region
determin
experiment
bioinformat
analys
primari
sequenc
nte
show
catalyt
nucleophil
number
locat
within
region
homolog
plant
protein
patatin
accordingli
one
name
ascrib
region
patatinhomolog
domain
nte
pnte
fig
base
initi
publish
structur
patatin
pdb
id
rydel
et
al
first
structur
homolog
model
pnte
present
wijeyesaker
et
al
paper
propos
pnte
consist
modifi
hydrolas
fold
central
parallel
flank
seven
subsequ
somewhat
higher
resolut
structur
publish
pdb
along
age
dfp
complex
pdb
nonag
complex
methyl
arachidonylfluorophosphon
mafp
pdb
wijeyesaker
et
al
previous
base
find
sitedirect
mutagenesi
catalyt
machineri
nte
thought
consist
novel
catalyt
triad
number
atkin
glynn
distinct
canon
serhisaspglu
triad
found
hydrolas
howev
current
view
akin
patatin
cpla
catalyt
center
nte
consist
catalyt
dyad
number
fig
residu
serv
gener
base
gener
acid
catalyt
process
thu
propos
hydrolysi
mechan
nte
involv
serv
gener
base
initi
stage
catalyt
process
activ
nucleophil
abstract
proton
allow
hydroxyl
oxygen
perform
nucleophil
attack
substrat
ensu
tetrahedr
intermedi
whose
neg
charg
expect
stabil
oxyanion
hole
nte
form
would
collaps
yield
acyl
enzym
intermedi
donat
proton
leav
group
therebi
serv
gener
acid
subsequ
engag
activ
water
molecul
would
allow
format
second
tetrahedr
intermedi
transit
state
result
releas
hydrolyz
substrat
regener
enzym
rydel
et
al
wijeyesaker
et
al
case
interact
nte
neuropath
op
compound
similar
mechan
propos
respons
format
organophosphyl
enzym
wijeyesaker
et
al
howev
addit
path
age
avail
op
compound
contain
linkag
por
pnhr
involv
loss
side
chain
via
n
possibl
loss
proton
singli
substitut
nitrogen
atom
phosphoramid
mipafox
reaction
result
perman
inhibit
enzym
johnson
postul
earli
johnson
thought
initi
factor
pathogenesi
opidn
ehrich
jortner
kropp
et
al
richardson
et
al
wijeyesaker
richardson
catalyt
serin
residu
also
resid
center
serin
lipas
motif
gxsxg
found
exampl
enzym
superfamili
phospholipas
turk
nte
sequenc
contain
addit
gxsxg
motif
residu
region
appear
disord
like
second
serin
lipas
motif
fals
posit
via
et
al
nevertheless
would
interest
determin
serin
residu
locu
subject
organophosphyl
locat
tm
domain
first
cnb
domain
pkab
domain
drosophila
nte
orthologu
sw
shown
bind
therebi
local
kinas
er
inhibit
activ
pkab
domain
also
appear
regul
esterasephospholipas
activ
sw
protect
neurodegen
effect
hyperact
bettencourt
da
cruz
et
al
howev
drosophila
opidn
model
tocp
produc
inhibit
sw
catalyt
activ
result
neurodegener
motor
deficit
increas
sw
level
overexpress
protect
wherea
decreas
sw
level
protect
neuropath
effect
tocp
suggest
gain
toxic
function
opinhibit
sw
tocp
treatment
result
signific
decreas
pka
activ
use
yeast
twohybrid
assay
mous
nte
shown
bind
drosophila
fli
overexpress
protect
behavior
deficit
produc
tocp
wentzel
et
al
base
drosophila
studi
mous
nte
bind
experi
similar
interact
human
nte
pka
expect
preliminari
investig
yet
confirm
interact
jkf
unpublish
observ
design
provision
site
domain
pkab
fig
current
boundari
hypothet
region
unknown
addit
predict
nlink
glycosyl
site
within
tm
domain
indic
phosphoryl
site
number
uniprot
fig
site
presum
would
regulatori
function
hirabayashi
et
al
walaa
greengard
yet
character
howev
interest
exposur
cell
chlorpyrifo
oxon
result
organophospyl
tyr
residu
protein
mani
residu
phosphoryl
site
protein
kinas
onder
et
al
thu
possibl
nte
could
organophospyl
site
catalyt
ser
residu
chemic
modif
protein
could
disrupt
normal
phosphorylationdephosphoryl
mediat
protein
kinas
phosphoprotein
phosphatas
given
presenc
ntermin
tm
domain
nte
unsurprisingli
character
membranebound
phospholipas
inde
associ
er
membran
evid
given
earli
subcellular
fraction
studi
hen
brain
homogen
show
enzym
concentr
within
microsom
fraction
richardson
et
al
result
confirm
subsequ
find
demonstr
need
nte
associ
membran
facilit
ntermin
tm
domain
li
et
al
furthermor
limit
proteolysi
ntecontain
microsom
reveal
protein
expos
cytoplasm
li
et
al
find
support
subsequ
coloc
studi
primari
cultur
mous
hippocamp
neuron
akassogl
et
al
bioinformat
analys
primari
sequenc
ntermin
region
nte
wijeyesaker
et
al
fluoresc
microscopi
studi
gfptag
nte
express
hek
cell
chang
et
al
contrast
er
local
nte
brain
signific
fraction
nte
activ
peripher
nerv
found
solubl
faction
vilanova
et
al
vilanova
et
al
current
role
solubl
form
appar
nte
activ
unclear
known
whether
aris
distinct
isoform
releas
er
transport
axon
solubl
protein
earli
work
indic
presenc
nte
variou
speci
tissu
base
enzym
activ
recent
augment
use
nextgener
sequenc
rna
transcript
tissu
rnaseq
result
confirm
express
wide
varieti
human
tissu
addit
nervou
system
lymphat
tissu
express
nte
particular
high
kidney
lung
testi
ncbi
convent
knockout
nte
mice
prove
lethal
embryon
day
disrupt
nte
gene
singl
allel
permit
surviv
nte
activ
level
reduc
normal
appar
structur
abnorm
nervou
system
winrow
et
al
lethal
due
complet
inactiv
nte
gene
mice
subsequ
attribut
placent
failur
impair
vasculogenesi
heterozyg
nte
mice
display
normal
organ
develop
despit
possess
nte
activ
normal
level
moser
et
al
connect
role
nte
placent
function
preeclampsia
human
associ
decreas
placent
nte
express
zhong
et
al
downregul
nte
gene
express
rna
interfer
mous
embryon
stem
cell
found
alter
multipl
pathway
involv
develop
respiratori
neural
vascular
system
effect
occur
nte
activ
inhibit
neuropath
op
compound
mipafox
sogorb
et
al
zebrafish
model
insuffici
creat
use
morpholino
oligonucleotid
knockdown
techniqu
embryo
result
development
abnorm
motor
neuron
defect
studi
also
show
signal
via
bone
morphogenet
protein
bmp
involv
phosphoryl
markedli
elev
knockdown
fish
phenotyp
could
rescu
human
wildtyp
mrna
mrna
contain
activesit
mutat
inactiv
catalyt
activ
song
et
al
bmp
pathway
also
implic
develop
hereditari
spastic
paraplegia
hsp
zhao
hedera
condit
knockout
cko
nte
cn
neuron
mice
carri
use
nestincreloxp
system
delet
neuron
nte
embryon
day
akassogl
et
al
brain
nte
activ
cko
mice
decreas
compar
wild
type
control
mice
brain
morpholog
cko
mice
appear
normal
week
age
week
mice
develop
er
disrupt
vacuol
neuron
hippocampu
thalamu
cerebellar
purkinj
cell
also
affect
function
cko
mice
exhibit
signific
decreas
rotarod
stay
time
second
cko
studi
mice
undertaken
order
investig
role
nte
defici
spinal
cord
axonopathi
neuron
ptdcho
homeostasi
neuron
secret
read
et
al
nestincreloxp
protocol
use
akassogl
et
al
follow
therefor
nte
defici
induc
embryon
day
axon
degener
found
cko
mice
age
day
gracil
nucleu
medullath
site
termin
long
ascend
tract
dorsal
column
spinal
cord
spinal
tract
lesion
ascend
descend
tract
consist
swollen
axon
progress
sever
number
cko
mice
period
mani
month
hindlimb
dysfunct
also
progress
period
brain
ptdcho
level
elev
nearli
month
remain
level
assess
month
rate
secret
two
protein
reelin
secret
fragment
amyloid
precursor
protein
sappa
impair
cultur
cerebellar
granul
cell
cko
mice
indic
moder
compromis
constitut
secretori
pathway
read
et
al
order
compar
cko
result
opidn
normal
mice
dose
oral
day
mgkg
neuropath
op
compound
mocp
arachi
oil
read
et
al
note
previous
mice
develop
clinic
sign
opidn
howev
possess
neural
nte
inhibit
acut
dose
neuropath
op
compound
makhaeva
et
al
develop
spinal
cord
lesion
follow
chronic
dose
tocp
lapadula
et
al
axon
degener
found
gracil
nucleu
week
start
mocp
dose
type
number
lesion
similar
seen
onemonthold
cko
mice
howev
lesion
mocpdos
mice
increas
number
sever
time
clinic
sign
hindlimb
dysfunct
appear
brain
ptdcho
level
modestli
elev
nearli
week
start
mocp
dose
return
baselin
week
rather
remain
elev
case
cko
nte
taken
togeth
result
interpret
indic
inactiv
nte
either
cko
sustain
inhibit
mocp
result
axon
degener
like
due
deficit
adult
axon
mainten
rather
effect
neurolog
develop
read
et
al
first
human
diseasecaus
mutat
nte
report
rainier
et
al
mutat
occur
catalyt
domain
produc
entiti
name
nte
motor
neuron
diseas
ntemnd
character
progress
spastic
paraplegia
childhood
lead
muscl
wast
lower
leg
intrins
muscl
hand
rainier
et
al
condit
subset
hereditari
spastic
paraplegia
hsp
condit
also
refer
mnd
construct
nte
catalyt
domain
contain
diseas
mutat
express
human
fibroblast
found
alter
enzymat
properti
compar
wildtyp
control
hein
et
al
construct
asymptomat
subject
heterozyg
mutat
predict
lack
residu
catalyt
domain
control
nte
activ
hein
et
al
find
consist
result
studi
nte
mice
control
nte
activ
appar
normal
nervou
system
develop
akassogl
et
al
moser
et
al
sinc
first
report
diseasecaus
mutat
human
nte
numer
addit
case
publish
indic
mutat
produc
broad
spectrum
neurodegen
condit
includ
boucherneuhaus
gordon
holm
syndrom
synofzik
et
al
topaloglu
et
al
well
olivermcfarlan
laurencemoon
syndrom
hufnagel
et
al
condit
present
clinic
wide
rang
deficit
includ
hypogonad
ataxia
retin
photoreceptor
degener
concomit
childhood
blind
kmoch
et
al
mutat
report
thu
far
locat
catalyt
domain
occur
cnb
region
nte
wildtyp
human
nte
express
sw
null
drosophila
mutant
movement
neurodegen
phenotyp
suppress
addit
elev
phospholipid
amelior
extent
howev
human
nte
contain
diseasecaus
mutat
express
sw
null
drosophila
movement
neurodegen
phenotyp
suppress
degre
none
human
mutant
effect
lipid
level
fli
human
nte
mutant
includ
mutat
catalyt
domain
other
mutat
region
contain
cnb
domain
result
interpret
indic
cnb
region
could
modul
nte
catalyt
activ
mutant
form
human
nte
retain
degre
biolog
function
suggest
disrupt
catalyt
function
sw
factor
diseas
pathogenesi
sunderhau
et
al
year
sinc
discoveri
nte
nearli
long
sinc
public
theori
inhibit
age
nte
nervou
system
requir
order
produc
opidn
johnson
johnson
sarqsar
data
accumul
period
larg
support
idea
opidn
result
combin
loss
physiolog
function
nte
inhibit
coupl
gain
toxic
function
format
age
nte
neg
charg
organophosphyl
group
coval
attach
activesit
serin
residu
richardson
et
al
hand
rel
recent
molecular
biolog
studi
tend
suggest
neurodegen
deleteri
effect
produc
loss
physiolog
function
nte
alon
rather
combin
loss
function
gain
toxic
function
studi
includ
employ
convent
winrow
et
al
condit
akassogl
et
al
read
et
al
knockout
gene
knockdown
zebrafish
neurogenet
find
human
subject
diseasecaus
nte
mutat
topaloglu
et
al
particular
investig
indic
sustain
absenc
nte
activ
andor
function
protein
isar
suffici
produc
neurodegen
effect
howev
toxicolog
data
least
genet
result
necessarili
mutual
exclus
case
diseasecaus
nte
mutat
vari
degre
inactiv
catalyt
activ
also
presenc
mutant
form
nte
might
parallel
situat
inhibit
age
nte
opidn
given
catalyt
function
nte
thought
concert
deacyl
ptdcho
yield
gropcho
ffa
system
inhibit
nte
activ
neuropath
op
compound
would
expect
result
increas
brain
ptdcho
level
howev
modest
transient
increas
produc
repeat
dose
mocp
mice
read
et
al
similarli
demonstr
chang
brain
ptdcho
concentr
follow
singl
larg
dose
tocp
pmsf
mice
hou
et
al
hen
hou
et
al
although
possibl
inhibit
level
andor
time
phospholipid
assay
prevent
detect
transient
rel
small
increas
ptdcho
level
inde
followup
studi
use
enhanc
lipidom
techniqu
found
signific
elev
ptdcho
lysoptdcho
level
hen
spinal
cord
microsom
fraction
day
singl
oral
dose
mgkg
tocp
chang
except
elev
ptdcho
prevent
pretreat
mgkg
pmsf
h
dose
tocp
interestingli
largest
increas
lipid
profil
seen
sphingomyelin
decreas
phosphatidylinositol
ptdin
zhu
et
al
substanti
persist
disrupt
lipid
homeostasi
found
sciatic
nerv
hen
given
singl
dose
mgkg
tocpptdcho
level
significantli
elev
much
day
return
control
level
day
xu
et
al
wherea
axon
lesion
opidn
describ
wallerian
degener
bouldin
cavanagh
earli
studi
lipid
chang
wallerian
degener
show
synthesi
ptdcho
elev
rat
sciatic
nerv
start
day
crush
injuri
natarajan
et
al
thu
possibl
increas
ptdcho
concentr
opidn
wallerian
degener
reflect
decreas
nte
activ
increas
ptdcho
synthesi
much
difficult
reconcil
cko
nte
result
toxicolog
find
although
number
caveat
rais
condit
knockout
gener
nestincreloxp
system
particular
harno
et
al
liang
et
al
yang
et
al
seem
unlik
cko
nte
mice
could
partial
disrupt
gene
give
rise
truncat
nte
protein
escap
detect
polyclon
antibodi
direct
catalyt
domain
region
enzym
akassogl
et
al
read
et
al
therefor
assum
cko
experi
result
complet
disrupt
gene
would
express
truncat
otherwis
abnorm
form
nte
protein
serv
counterpart
inhibitedag
nte
opidn
howev
given
nestincreloxp
system
initi
cko
nte
start
embryon
day
possibl
remain
result
neurolog
abnorm
reflect
neurodevelopment
sequela
absenc
nte
protein
enzymat
activ
although
neuropatholog
chang
spinal
cord
cko
mice
similar
appear
mocpdos
mice
read
et
al
axon
degener
aris
wide
rang
caus
similar
appear
distribut
lesion
coleman
likewis
knockdown
experi
zebrafish
indic
suppress
critic
amount
suffici
caus
motor
neuron
defect
abnorm
knockdown
done
embryon
develop
song
et
al
observ
effect
result
neurodevelopment
phenomena
rather
effect
adult
axon
mainten
moreov
adult
zebrafish
brain
nte
inhibit
follow
dose
cbdp
dfp
behavior
deficit
spinal
cord
histopatholog
lesion
detect
addit
thorough
lipidom
analysi
detect
small
increas
brain
lysophospholipid
hour
dfp
follow
cbdp
chang
brain
ptdcho
result
treatment
either
inhibitor
author
conclud
zebrafish
good
model
human
opidn
faria
et
al
johnson
note
neuropath
op
compound
one
thing
commonth
abil
age
inhibit
nte
accordingli
reason
age
protein
serv
signal
initi
axon
degener
loss
nte
catalyt
activ
seem
irrelev
induct
lesion
nonag
compound
inhibit
nte
without
produc
opidn
furthermor
nonag
inhibitor
nte
inert
pretreat
anim
nonag
inhibitor
confer
protect
opidn
subsequ
dose
age
inhibitor
long
inhibit
level
pretreat
carrington
johnson
johnson
johnson
read
moretto
et
al
howev
also
true
age
compound
necessarili
result
longerterm
inhibit
least
nonag
inhibitor
eg
carbam
age
inhibitor
yield
highli
stabl
organophosphyl
nte
undergo
spontan
reactiv
thu
recoveri
nte
activ
follow
inhibit
ageabl
inhibitor
depend
sole
upon
resynthesi
enzym
rather
combin
resynthesi
reactiv
nevertheless
prolong
inhibit
nte
also
produc
variou
dose
regimen
nonag
inhibitor
repeat
dose
carbam
singl
repeat
dose
phosphin
singl
repeat
dose
sulfonyl
fluorid
pmsf
nte
inhibit
phosphin
reactiv
vitro
kf
oxim
nte
inhibit
pmsf
appar
reactiv
either
spontan
power
nucleophil
yet
despit
prolong
inhibit
nonag
inhibitor
nte
axon
degener
produc
meredith
johnson
richardson
et
al
possibl
resolut
appar
paradox
concern
nonag
nte
inhibitor
propos
nonspecif
could
theoret
inhibit
serin
hydrolas
whose
inactiv
would
serv
negat
loss
nte
activ
wijeyesaker
richardson
human
genom
encod
serin
hydrolas
least
half
function
character
lenfant
et
al
simon
cravatt
howev
would
seem
simpler
explan
nonpathogen
protect
afford
nonag
nte
inhibitor
compound
lack
distinct
common
featur
age
inhibitorsth
abil
place
neg
charg
phosphyl
group
activ
site
nte
johnson
especi
consid
nonag
phosphin
inhibitor
exhibit
high
potenc
select
nte
thu
neurotoxicolog
perspect
left
two
theoret
possibl
opidn
result
presenc
age
nte
opidn
result
combin
nte
inhibit
plu
presenc
age
protein
practic
matter
order
produc
age
nte
necessari
first
inhibit
enzym
ageabl
inhibitor
therefor
toxicolog
data
ultim
lead
conclus
opidn
requir
inhibit
age
nte
refer
back
neurogenet
find
summar
would
appear
diseasecaus
nte
mutat
could
produc
neurodegener
via
loss
nte
activ
andor
presenc
abnorm
form
nte
protein
hand
knockdown
cko
nte
like
produc
neurodegener
loss
nte
protein
concomit
absenc
enzymat
activ
andor
defici
unknown
function
domain
event
import
bear
mind
thu
far
neurogenet
find
distinguish
development
effect
versu
effect
mainten
healthi
nervou
system
adult
consider
toxicolog
neurogenet
find
review
propos
two
hypothet
model
help
guid
futur
research
elucid
role
nte
opidn
phospholipid
homeostasi
disrupt
phd
opinduc
wallerian
degener
opiwad
necessarili
mutual
exclus
model
inde
could
well
view
sequenti
wherebi
disrupt
axon
transport
phd
model
could
serv
trigger
axon
degener
via
opiwad
model
fig
depict
hypothet
phospholipid
homeostasi
disrupt
phd
model
show
partial
pathway
phospholipid
metabol
neuron
model
repres
synthesi
lipid
hypothesi
wijeyesaker
richardson
togeth
extens
mammalian
system
model
base
studi
yeast
glynn
glynn
model
final
stage
ptdcho
synthesi
take
place
golgi
product
retrograd
transport
er
ptdcho
ptdin
transport
protein
pitp
mammalian
homologu
yeast
transport
protein
wyckoff
et
al
despit
name
origin
discov
function
shuttl
ptdin
membran
compart
pitp
also
accommod
ptdcho
cargo
carvou
et
al
grabon
et
al
fig
pathway
hypothes
fraction
ptdcho
transport
er
complex
pitp
degrad
nte
liber
pitp
process
glynn
glynn
function
nte
defici
increas
fraction
avail
pitp
pool
would
remain
associ
ptdcho
rather
becom
avail
transport
ptdin
golgi
result
defici
ptdin
concomitantli
phosphoryl
ptdin
golgi
would
compromis
constitut
secretori
pathway
axon
transport
thu
precipit
axon
degener
bartlett
et
al
lorenzo
et
al
connect
noteworthi
disrupt
axon
transport
shown
preced
clinic
sign
opidn
hen
treat
neuropath
op
compound
gupta
et
al
moretto
et
al
addit
nte
shown
undergo
fast
axon
transport
hen
sciatic
nerv
carrington
aboudonia
contrast
pathway
fig
involv
direct
deacyl
free
ptdcho
nte
compromis
function
nte
would
affect
pitp
level
ptdin
could
function
normal
support
constitut
secretori
pathway
axon
transport
thu
neuropath
op
compound
would
expect
preferenti
inhibit
pathway
wherea
nonneuropath
protect
nte
inhibitor
would
expect
preferenti
inhibit
pathway
partial
pathway
phospholipid
metabol
neuron
shown
cholin
cho
taken
cell
phosphoryl
cholin
kinas
ck
phosphocholin
pcho
convert
cytidin
diphosphatecholin
cdpcho
via
cytidin
triphosph
phosphocholin
cytidyltransferas
cct
catalysi
final
step
carri
golgi
involv
addit
diacylglycerol
dag
cdpcho
catalyz
cholin
phosphotransferas
cpt
form
phosphatidylcholin
ptdcho
ptdcho
product
form
complex
phosphatidylcholinephosphatidylinositol
transport
protein
pitp
convey
ptdcho
endoplasm
reticulum
er
releas
uncomplex
pitp
back
cytoplasm
pathway
fraction
ptdcho
transport
er
deacyl
nte
glycerophosphocholin
gropcho
two
free
fatti
acid
ffa
releas
free
pitp
process
pathway
involv
deacyl
ptdcho
er
gropcho
ffa
pathway
depict
hydrolysi
ptdcho
phospholipas
lysophosphatidylcholin
lysoptdcho
degrad
nte
gropcho
ffa
phosphatidylinositol
ptdin
er
transport
via
pitp
golgi
phosphoryl
phosphatidylinositol
kinas
pik
variou
phosphoryl
ptdin
speci
ptdinsp
help
regul
constitut
secretori
pathway
axon
transport
color
blue
pitp
pathway
green
golgi
magenta
lysoptdcho
ffa
form
hydrolysi
red
enzym
yellow
er
see
text
explan
nte
inactiv
model
could
precipit
opidn
carvou
et
al
glynn
glynn
marcucci
et
al
ong
et
al
fig
involv
one
nonnt
phospholipas
enzym
hydrolyz
ptdcho
directli
lysoptdcho
would
expect
rapidli
degrad
nte
yield
gropcho
ffa
howev
nte
preferenti
inhibit
lysoptdcho
could
increas
injuri
level
lead
axon
degener
de
et
al
hand
preferenti
inhibit
activ
would
block
lysoptdcho
format
thu
confer
protect
nte
inhibit
wijeyesaker
richardson
inde
inhibitor
variou
brain
enzym
consid
import
neuropharmacolog
class
agent
treatment
multipl
neurolog
disord
denni
et
al
farooqui
et
al
ong
et
al
model
provid
conceptu
framework
understand
potenti
action
neuropath
nonneuropath
nte
inhibitor
initi
prevent
axon
degener
wallerian
degener
relationship
opidn
discuss
insight
histopatholog
observ
opidn
histopatholog
produc
tocp
hen
cavanagh
describ
spatialtempor
evolut
lesion
spinal
cord
peripher
nerv
process
primari
axon
degener
follow
demyelin
close
resembl
wallerian
degener
induc
cut
crush
spinal
cord
tract
peripher
nerv
also
note
lesion
similar
seen
thiamin
defici
result
slow
energi
metabol
lead
degener
distal
axonsth
nerv
cell
compon
farthest
cell
bodi
followup
studi
opidn
produc
dfp
cat
bouldin
cavanagh
describ
lesion
chemic
transect
axon
precipit
wallerian
degener
origin
describ
waller
wallerian
degener
consid
next
year
passiv
degen
processa
consequ
separ
distal
axon
vital
substanc
suppli
cell
bodi
waller
investig
oxford
univers
made
astound
discoveri
strain
mous
whose
distal
axon
remain
intact
rel
long
period
follow
transect
peripher
nerv
lunn
et
al
ultim
caus
axon
resili
found
mutat
aptli
name
wallerian
degener
slow
wld
discoveri
serendipit
mutat
aros
spontan
permit
detect
coincident
becom
homozyg
revel
wld
fundament
chang
concept
wallerian
degener
passiv
process
activ
program
axon
selfdestructiona
kind
local
apoptosi
confin
axon
gerdt
et
al
exposur
neuropath
age
op
nte
inhibitor
produc
inhibit
age
nte
trigger
wallerian
degener
via
inhibit
axon
transport
andor
stimul
mitogenactiv
protein
kinas
mapk
andor
associ
kinas
cascad
pathway
nicotinamid
mononucleotid
adenylyltransferas
prosurviv
factor
continu
suppli
axon
via
axon
transport
block
steril
alpha
tollinterleukin
receptor
tir
motif
contain
deplet
nicotinamid
adenin
dinucleotid
nad
level
activ
kinas
cascad
lower
level
enabl
deplet
nad
lead
atp
deplet
result
energi
crisi
increas
ca
concentr
extern
intern
er
mitochondri
sourc
therebi
activ
calciumactiv
neutral
proteas
canp
calpain
degrad
axon
protein
result
axon
degener
nonag
nte
inhibitor
block
format
age
nte
confer
protect
opidn
block
initi
execut
phase
wallerian
degener
axonopathi
amelior
ca
channel
blocker
andor
canp
inhibitor
calpastatin
compon
model
block
axonopathi
shown
green
nte
color
blue
conforti
et
al
rosel
neukomm
walker
et
al
ultim
establish
wld
protect
axon
degener
gain
function
manner
code
stabl
fusion
protein
substitut
labil
cytosol
nicotinamid
mononucleotid
adenyltransferas
enzym
catalyz
format
nicotinamid
adenin
dinucleotid
nad
essenti
cofactor
numer
enzymat
pathway
includ
involv
redox
reaction
energi
metabol
product
energi
currenc
cell
adenosin
triphosph
atp
coleman
freeman
normal
axon
degrad
rapidli
constantli
resuppli
cell
bodi
axon
transport
disrupt
axon
transport
injuri
diseas
certain
neurotox
agent
interrupt
suppli
quickli
lead
nad
deplet
follow
close
loss
atp
result
local
energi
crisi
permit
intraaxon
calcium
level
rise
sharpli
therebi
activ
calciumactiv
neutral
proteas
canp
calpain
mediat
destruct
axon
given
central
role
prosurviv
factor
help
maintain
axon
healthi
state
gilley
coleman
tightli
regul
multipl
pathway
process
includ
camp
signal
protein
phosphoryl
cascad
palmitoyl
ubiquitin
ligas
geden
deshmukh
rosel
neukomm
complementari
studi
identifi
prodegen
factor
pathway
includ
steril
alpha
receptor
motifcontain
protein
kinas
mapk
cascad
loss
function
mutat
blockad
mapk
pathway
confer
protect
axon
degener
induc
variou
trigger
includ
physic
chemic
agent
convers
activ
andor
mapk
pathway
trigger
axon
degener
possibl
decreas
stabil
thu
lead
deplet
nad
atp
lore
thompson
wallerian
degener
appear
biphas
process
consist
initi
phase
earli
event
contribut
nad
deplet
follow
latent
period
execut
phase
coleman
freeman
precis
event
mark
transit
one
stage
anoth
still
investig
appear
execut
interv
entail
increas
intraaxon
ca
concentr
activ
canp
contribut
dissolut
axon
conforti
et
al
howev
calcium
entri
andor
releas
calcium
intern
storag
site
er
mitochondria
could
also
occur
initi
phase
even
toxic
neuropathi
involv
physic
trauma
axon
exampl
hour
neuropath
dose
tocp
hen
canp
activ
significantli
elev
sciatic
nerv
administr
calciumchannel
blocker
nimodipin
within
hour
tocp
effect
normal
canp
activ
measur
hour
day
posttocp
treatment
partial
effect
amelior
clinic
sign
opidn
assess
day
posttocp
emerick
et
al
addit
pathway
target
modul
initi
andor
execut
wallerian
degener
continu
discov
among
asyet
unidentifi
serin
proteas
whose
inhibit
delay
neurit
degener
primari
neuron
cultur
conforti
et
al
surprisingli
mitochondria
implic
wallerian
degener
barriento
et
al
studi
ongo
determin
whether
mitochondri
perturb
correspond
caus
effect
well
initi
execut
phase
axon
degener
conforti
et
al
howev
recent
work
indic
inhibit
mitochondri
respir
downstream
event
axon
degener
trigger
activ
via
cjun
ntermin
kinas
jnk
mediat
phosphoryl
murata
et
al
particular
relev
opidn
fact
mani
regulatori
pathway
wallerian
degener
involv
balanc
action
protein
kinas
phosphoprotein
phosphatas
phosphoryl
dephosphoryl
protein
ali
et
al
araki
wakatsuki
murata
et
al
process
oper
side
oppos
forc
prosurviv
prodegen
pathway
exampl
conceiv
organophosphyl
age
nte
could
serv
signal
initi
wallerian
degener
propos
previous
yet
rigor
test
richardson
furthermor
chemic
modif
nte
nonag
adduct
might
confer
protect
axonopathi
maintain
level
block
activ
mapk
pathway
walker
et
al
apropo
concept
studi
organophosphyl
protein
vitro
vivo
exposur
op
insecticid
nerv
agent
cours
found
op
adduct
esterat
ser
residu
black
read
graham
et
al
addit
investig
detect
op
adduct
nonesterat
thi
tyr
ly
residu
multipl
protein
includ
ubiquitin
john
et
al
john
et
al
onder
et
al
schmidt
et
al
schopfer
lockridg
moreov
mani
opadduct
residu
phosphoryl
site
protein
kinas
studi
shown
op
compound
disrupt
kinasemedi
phosphoryl
drosophila
rat
cell
mous
brain
result
hypoor
hyperphosphoryl
specif
regulatori
site
batista
et
al
felemban
et
al
zhu
et
al
addit
op
compound
react
directli
ly
residu
protein
form
isopeptid
crosslink
glu
asp
residu
tubulin
modifi
manner
form
high
molecular
weight
intermolecular
aggreg
schmidt
et
al
schopfer
lockridg
taken
togeth
find
clearli
demonstr
possibl
exposur
op
compound
could
disrupt
physiolog
pathogen
process
regul
protein
phosphoryl
dephosphoryl
event
normal
mediat
protein
kinas
phosphoprotein
phosphatas
event
known
includ
induct
prevent
wallerian
degener
note
previous
nte
least
six
nonesterat
phosphoryl
site
uniprot
could
candid
disrupt
organophosphyl
despit
consider
advanc
made
understand
physiolog
pathogen
role
nte
sinc
discoveri
remain
major
obstacl
make
progressth
lack
structur
protein
fact
nte
larg
membranebound
multidomain
molecul
hinder
structur
determin
xray
crystallographi
nevertheless
solv
individu
domain
undertaken
use
xray
nmr
techniqu
puthenveetil
vinogradova
determin
domain
interact
approach
combin
sitedirect
fluoresc
chemic
crosslink
isotop
exchang
mass
spectrometri
hodg
et
al
raghuraman
et
al
xiang
et
al
addit
cryogen
electron
microscopi
recent
emerg
ideal
techniqu
solv
structur
difficult
protein
resolut
approach
xray
method
nwanochi
uverski
schur
meantim
work
structur
dynam
nte
progress
use
coordin
suit
comput
molecular
model
approach
includ
iter
thread
global
explor
loop
perturb
coarsegrain
molecular
dynam
simul
singh
lee
subsequ
silico
mutagenesi
coval
dock
use
studi
alter
structur
flexibl
stabil
nte
induc
mutat
chemic
modif
age
vs
nonag
inhibitor
doer
et
al
scarpino
et
al
current
comput
work
nte
catalyt
domain
shown
patatinlik
protein
plpd
better
templat
patatin
creat
homolog
model
rjr
unpublish
observ
plpd
virul
factor
phospholipas
activ
secret
pseudomona
aeroginosa
bacterium
commonli
associ
opportunist
hospitalacquir
infect
da
mata
madeira
et
al
foulk
et
al
similarli
replic
coronavirus
flavivirus
shown
involv
manipul
host
phospholipid
homeostasi
via
activ
phospholipas
enzym
inhibit
activ
compromis
viral
replic
liebscher
et
al
uller
et
al
find
suggest
entir
new
direct
futur
work
nte
help
inform
studi
import
human
pathogen
thirti
year
ago
mk
johnson
publish
contemporari
issu
toxicolog
articl
titl
organophosph
delay
neuropathyi
nte
aliv
well
report
statu
understand
nte
mechan
opidn
along
outlin
use
knowledg
intellig
econom
assess
rel
neurotoxicolog
risk
exposur
op
compound
end
articl
word
encourag
also
serv
call
action
work
lead
evergreat
understand
johnson
fit
requot
word
say
use
lamp
dark
whose
fault
stumbl
attribut
gilbert
newminst
ca
winston
churchil
said
give
us
tool
finish
job
lamp
tool
